Towards Automated Monitoring of Parkinson's Disease Following Drug Treatment
Pattern Recognition and Artificial Intelligence. ICPRAI 2022 · Université Paris Cité, Paris, France · June 2022
I talked about an automated approach to the clinical monitoring of Parkinson's disease (PD) by applying Evolutionary Algorithms (EAs) to resting-state functional magnetic imaging (rs-fMRI) data. The novel application of EAs to both map and predict the functional connectivity is considered in patients receiving the drug Modafinil versus placebo.